China Pharma Holdings
CPHI
4 hedge funds and large institutions have $12.8K invested in China Pharma Holdings in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.01% less ownership
Funds ownership: 0.04% → 0.03% (-0.01%)
9% less capital invested
Capital invested by funds: $14K → $12.8K (-$1.2K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| 1 |
TSS
Two Sigma Securities
New York
|
+$4.2K |
| 2 |
MG
Marex Group
London,
|
+$2.96K |
Top Sellers
| 1 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$4.11K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.71K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$1.58K |
CPHI Hedge Fund Activity: Q3 2024 in Review
4 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2024, worth a combined $12.8K — down 8.6% from $14K a quarter earlier.
Fund positioning in CPHI was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $4.2K. The largest seller was Baader Bank Aktiengesellschaft, exiting entirely with an estimated $4.11K sold.
- 4 institutional investors held China Pharma Holdings (CPHI) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $12.8K of China Pharma Holdings stock for Q3 2024, down 8.6% quarter-over-quarter.
- 2 funds opened new China Pharma Holdings positions in Q3 2024 and 2 closed out, a net change of 0 holders.
- The largest China Pharma Holdings buyer in Q3 2024 was Two Sigma Securities, an estimated $4.2K added.
- The largest China Pharma Holdings seller in Q3 2024 was Baader Bank Aktiengesellschaft, an estimated $4.11K sold.
Based on aggregated 13F filings for Q3 2024.